OrphanDrug
OrphanDrug
Pharma Knowledge Base

Swissmedic Compassionate Use – Switzerland

Swissmedic Compassionate Use ApplicationTherapeutic Products Act (HMG/LPTh)30 days

Contents

  1. 1. Description & Eligibility
  2. 2. Countries Using This Pathway

Description & Eligibility

Swissmedic allows compassionate use of medicines not yet authorised in Switzerland for patients with serious or life-threatening diseases under the Therapeutic Products Act.

Eligibility Criteria

Serious or life-threatening condition with no locally registered alternative

Legal Reference / Source

Swissmedic Compassionate Use Guidance

Countries Using This Pathway (1)

CH
Switzerland
CH
Swissmedic Compassionate Use – Switzerland
Approval FormSwissmedic Compassionate Use Application
Timeline30 days
Legal StatusTherapeutic Products Act (HMG/LPTh)
Source Ref.Swissmedic Compassionate Use Guidance
Countries1 countries
Compliance Check
Legal Review3/11/2026
Global ValidityVerified